English Korean Chinese
ホーム > 市場調査レポート > バイオテクノロジー > ゲノム創薬 > 欧州の創薬市場におけるバイオインフォマティクスの機会
カテゴリ
バイオテクノロジー (1630)
オーダーメイド医療 (51)
ゲノム創薬 (203)
バイオマーカー (158)
バイオマテリアル (54)
バイオ機器 (385)
遺伝子療法/RNAi (103)
抗体/免疫 (194)
再生医療 (122)
分子標的療法 (132)
市場調査レポート

欧州の創薬市場におけるバイオインフォマティクスの機会

Opportunities for Bioinformatics in European Drug Discovery Markets

発行 Frost & Sullivan
出版日 2007年04月 商品コード 51634
ページ情報 英文  
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This Frost & Sullivan research service titled Opportunities for Bioinformatics in European Drug Discovery Market provides a detailed analysis of the key factors driving growth in the European bioinformatics industry in the drug discovery market. The study also covers the basic aspects of bioinformatics including the segmentation pattern and the challenges faced by market participants.

Table of Contents

1. Executive Summary

  • 1. Summary of Findings
    • 1. Summary

2. Glossary

  • 1. Glossary of Terms
    • 1. Glossary

3. Research Methodology

  • 1. Methodology Adopted
    • 1. Methodology

4. Overview of Challenges Faced by the Bioinformatics Industry

  • 1. Challenges Faced by the Bioinformatics Industry
    • 1. Challenges

5. European Bioinformatics Market

  • 1. Market Overview
    • 1. Overview
  • 2. Segmentation
    • 1. Market Segment
  • 3. Market Drivers
    • 1. Drivers
      • a. Increasing Demand for Advanced Data Handling Tools
      • b. Need to Develop Tools to Increase Drug Research Productivity
      • c. Increasing R&D Spend of the Government
      • d. Increasing Trend towards Dry Lab Techniques
      • e. Increasing Use of High Throughput Systems
      • f. Need to Eliminate False Leads and Cut Costs
  • 4. Market Restraints
    • 1. Restraints
      • a. Pharmaceutical Research Gradually Relocating from Europe
      • b. European Companies' Conservative Attitude towards New Technologies
      • c. Proprietary and Incompatible Data Formats
      • d. Saturated Large Pharma Market
      • e. Attitude of Limited IT Spending
  • 5. Revenue Forecasts
    • 1. Revenue Forecasts
  • 6. Geographical Trends
    • 1. Geographic Trends
  • 7. Competitive Analysis
    • 1. Competitive Structure
  • 8. Company Profiling
    • 1. Company Profiles

6. Genomic Market

  • 1. Genomic Market in Europe
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts

7. Proteomics Market

  • 1. Proteomics Market in Europe
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts

8. Information Manipulation Market

  • 1. Information Manipulation Market in Europe
    • 1. Introduction
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts

9. Geographic Trends

  • 1. European Bioinformatics Market
    • 1. Overview
  • 2. UK Bioinformatics Market
    • 1. Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
  • 3. German Bioinformatics Market
    • 1. Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
  • 4. French Bioinformatics Market
    • 1. Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
  • 5. Scandinavian Bioinformatics Market
    • 1. Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts
  • 6. Benelux Bioinformatics Market
    • 1. Overview
    • 2. Market Engineering Measurements
    • 3. Revenue Forecasts

10. Strategic Recommendations

  • 1. Recommendations
    • 1. Strategies

11. Database of Key Industry Participants

  • 1. Key Industry Participants
    • 1. Database of Key Industry Participants

12. Appendix

  • 1. Decision Support Database
    • 1. Decision Support Database

List of Figures

Chapter 4
  • Opportunities for Bioinformatics in European Drug Discovery Market: Market Challenges Ranked in Order of Impact (Europe), 2006-2013

Chapter 5
  • Traditional Method of Drug Discovery
  • Modern Method of Drug discovery
  • Market Segmentation of European Bioinformatics Market
  • Opportunities for Bioinformatics in European drug Discovery Market: Market Drivers Ranked in Order of Impact (Europe), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery Market: Market Restraints Ranked in Order of Impact (Europe), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts (Europe), 2006-2013
  • Opportunities for Bioinformatics in European drug Discovery Market: Competitive Structure (Region), 2006

Chapter 6
  • Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Genomic Segment (Europe), 2006-2013

Chapter 7
  • Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Proteomic Segment (Europe), 2006-2013

Chapter 8
  • Opportunities for Bioinformatics in European Drug Discovery Market: Revenue Forecasts for Information Manipulation Segment (Europe), 2006-2013

Chapter 9
  • Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (United Kingdom), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Germany), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (France), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Scandinavia), 2006-2013
  • Opportunities for Bioinformatics in European Drug Discovery market: Revenue Forecasts (Benelux), 2006-2013
Back to Top